Navigation Links
AUDIO from Medialink and UnitedHealthcare: Medicare Annual Enrollment Begins November 15th
Date:10/2/2008

NEW YORK, Oct. 2 /PRNewswire/ -- Americans with Medicare who are considering a prescription drug plan have an important decision to make soon.

Listen to this report from United Healthcare at: http://media.medialink.com/WebNR.aspx?story=35783

Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://www.mediaseed.tv.

10DC08-0027


'/>"/>
SOURCE Medialink and UnitedHealthcare
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. AUDIO from Medialink and the AWP Track 2 Settlement Administrator: AWP Settlement
2. AUDIO from Medialink and the Association for Dressings and Sauces: Pass The Mayo! Myths Dispelled During Septembers National Food Safety Education Month
3. AUDIO from Medialink and Nationwide Childrens Hospital: Skyrocketing Kids Suicide Numbers Still High
4. AUDIO from Medialink and Pfizer: Community Health Centers Celebrated for Making Quality Care Available to Uninsured Americans
5. AUDIO from Medialink and BP: Younger for Longer
6. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
7. AUDIO OF CONFERENCE CALL: National Disability Rights Leaders Dubious Over John McCains Possible Switch on Community Choice Act, Says DNC
8. AUDIO from Medialink and Duramed Pharmaceuticals: Not Your Mothers Menopause
9. New York Transcription Company Finds Digital Audio Recordings Still Problematic
10. Nelson Mandelas Favorite African Folktales to be Produced as Audiobook Featuring Archbishop Tutu, Gillian Anderson, America Ferrera, Whoopi Goldberg, Samuel L. Jackson, Alan Rickman and Jurnee Smollett, Directed by Alfre Woodard
11. AUDIO from Medialink and Duramed Pharmaceuticals: Relief for Women Experiencing Surgical Menopause

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...uld boost self-esteem, researchers say , ...ldren are more likely to have handwriting problems...thout autism, researchers say. , The new study ...udy participants had autism spectrum disorder, but...e for perceptual reasoning on an IQ test. , The...
(Date:11/9/2009)...ned sexual function, study says, , , ...e able to restore sexual function to rabbits with ...e lab and implanting it, a new study reports. ,...hers say the technique could one day be used to tr...ere able to show the tissue was able to integrate ...
(Date:11/9/2009)...ire-FirstCall/ - Hard To Treat Diseases (HTDS.PK) ...is, a US$41 billion international healthcare compa...e partner, Zhejiang Tianyuan Bio-Pharmaceutical Co...nd will begin a five-year, $1 billion China initia...increase its investment in its China R&D facil...
(Date:11/9/2009)... be too late when it comes to preventing or improv...Inc. (Take Off Pounds Sensibly), the nonprofit wei... (Vocus) November 9, 2009 -- Tomorrow may b...g a diabetes condition, according to TOPS Club, In...t-loss support organization., , ,Diabetes is a dis...
(Date:11/9/2009)...ghlights positive influence of sports participatio...nt, IL (Vocus) November 9, 2009 -- As people age f...t research has highlighted the importance of exerc...issues. However, a new study published in the Nove...iplinary Approach reveals that there may be signi...
Breaking Medicine News(10 mins):Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2
... city to live in for springtime sufferers, , ...le, Ky., is the most challenging place to live for...thma and Allergy Foundation of America,s 2009 list... with allergies. The rankings are published annual...
...ferent accents every day. Even when a speaker of a...y than we do, we are typically able to recognize t... Laboratories, University of Western Sydney, along...l, which they term "phonological constancy." , In...
...ge from $1.5 Million - $3 Million , , PRINCETON, ...ard: DSCI), a manufacturer and marketer of advance...ed a new contract to supply private label adhesive...lion for Derma Sciences. Shipments to the custome...
...ic alliance has formed in the global battle agains...rass-roots movement Susan G. Komen for the Cure gi...st Cancer Conference, co-organized by the Breast I...fit funds for the fight against breast cancer. To ...
...cognized Nationally - , , WASHINGTON, May 6 /PR...field, Ind., has been named the National Youth Adv... Kids for her leadership in the fight against toba...w.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) ...
...A, May 6 Physicians, Choice, a medical billing se...et, has successfully implemented InstaMed,s singl...includes both payment and clearinghouse solutions....ering new value to the revenue cycle by accelerati...
Other Medicine News:Health News:Derma Sciences Announces New Contract With Major Medical Products Supplier for Private Label Adhesive Bandages 2Health News:Derma Sciences Announces New Contract With Major Medical Products Supplier for Private Label Adhesive Bandages 3Health News:Transatlantic alliance supports breast cancer research 2Health News:Campaign for Tobacco-Free Kids Honors Emily Kile, Greenfield, IN, as National Youth Advocate of the Year 2Health News:Physicians' Choice Leverages InstaMed's Integrated Platform for Healthcare Payment & Clearinghouse Solutions 2Health News:Physicians' Choice Leverages InstaMed's Integrated Platform for Healthcare Payment & Clearinghouse Solutions 3
(Date:11/9/2009)..., Pa., Nov. 9 ARmark Authenticatio...today an alliance in the development and introduct...ntication technology that incorporates microscopic... coatings of solid oral dosage forms (SODFs) to pr...on exclusive rights to market ARmark,s micro-tags ...
(Date:11/9/2009)... Oregon, November 9 Bend Research ...nce in applying innovative pharmaceutical,technolo...ientific and,technical problems, announced today t...x Pharmaceuticals Incorporated, a global biotechno..., Through this new collaboration, Vertex will ...
(Date:11/9/2009)...ov. 9 PAREXEL Internatio... biopharmaceutical services provider, today announ...lities for early phase clinical development throug... manufactures and distributes electrocardiogram (E...XEL is using Mortara Instrument,s Surveyor Telemet...
Breaking Medicine Technology:ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results 13493 1Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results 13493 2Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 1Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly 242 Billion in 2018 13490 2BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 13488 1BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 13488 2BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 13488 3BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 13488 4
...al Meeting -, - Conference call to be hosted toda..., Conn., Nov. 3 CuraGen Corporation,(Nasdaq: CRG...ng Phase II,trial of CR011-vcMMAE, an antibody-dru...of patients with unresectable Stage III or Stage I...ator, and Professor and Chairman of,the Department...
...ented at AASLD annual meeting, Pivotal Phase III ...ose,who failed prior treatment, SAN FRANCISCO, No...day reported that a planned interim analysis of a,...gational oral hepatitis C,protease inhibitor, in c...ly increased sustained virologic response (SVR) ra...
Other Medicine Technology:CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 2Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 3Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 4Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 5Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 6Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 7Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 8Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 9Boceprevir Phase II Study Showed High Rate of Sustained Response With 28- and 48-Week Regimens in Genotype 1 Treatment-Naive Hepatitis C Patients 10
...gulation (ECP) is a surgical approach to glaucoma ...lized laser application. The ciliary body (which p...from the anterior or posterior segment, through th...asily and accurately identified utilizing endoscop...
Moore Hyperopic Flap Conformer, 48 Diopter
...gulation (ECP) is a surgical approach to glaucoma ...lized laser application. The ciliary body (which p...from the anterior or posterior segment, through th...asily and accurately identified utilizing endoscop...
...gulation (ECP) is a surgical approach to glaucoma ...lized laser application. The ciliary body (which p...from the anterior or posterior segment, through th...asily and accurately identified utilizing endoscop...
Medicine Products: